Publications by authors named "Alan Bryce"

Claim this Profile
C
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis.
Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Kunwer Sufyan Faisal, Huan He, Kaneez Zahra Rubab Khakwani, Alan Haruo Bryce

Eur Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.
Nicolas Sayegh, Ryon P Graf, Umang Swami, Zeynep Irem Ozay, Chadi Hage Chehade, Alan H Bryce

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2).
Anthony V Serritella, Amy Taylor, Michael C Haffner, Wassim Abida, Alan Bryce

Prostate Cancer Prostatic Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2).
Andrew J Armstrong, Amy Taylor, Michael C Haffner, Wassim Abida, Alan H Bryce

Prostate Cancer Prostatic Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer.
Sigrid V Carlsson, Pedro C Barata, Alan H Bryce, Daniel J George, Silke Gillessen

JCO Oncol Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thromboembolic Events in Castration-Resistant Prostate Cancer Patients With and Without Cardiovascular Comorbidities Receiving Oral Androgen Receptor Pathway Inhibitors.
Ibrahim M Asiri, Ronald C Chen, Viraj Master, Lanyu Mi, Sarah E James, Alan H Bryce

Prostate· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.
Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, R Bryan Rumble, Mary-Ellen Taplin, Alan H Bryce

J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer.
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, Catherine H Marshall, Kelly L Stratton, Alan H Bryce

Prostate Cancer Prostatic Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer.
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, Catherine H Marshall, Kelly L Stratton, Alan H Bryce

Prostate Cancer Prostatic Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer.
Francesca Zacchi, Wassim Abida, Emmanuel S Antonarakis, Alan H Bryce, Elena Castro

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.
Neal Shore, Sarah M Nielsen, Edward D Esplin, Emmanuel S Antonarakis, Pedro C Barata, Alan Bryce

JCO Oncol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis.
Syed Arsalan Ahmed Naqvi, Irbaz Bin Riaz, Arifa Bibi, Muhammad Ali Khan, Manal Imran, Alan H Bryce

Eur Urol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment switching between Enzalutamide and Abiraterone Acetate and time to oral opioid initiation in castration-resistant prostate cancer patients.
Ibrahim M Asiri, Ronald C Chen, Viraj Master, Lanyu Mi, Sarah E James, Alan H Bryce

Cancer Epidemiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic treatment options for metastatic castration resistant prostate cancer: A living systematic review.
Syed Arsalan Ahmed Naqvi, Muhammad Umair Anjum, Arifa Bibi, Muhammad Ali Khan, Kaneez Zahra Rubab Khakwani, Alan H Bryce

medRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis.
Osama Mosalem, Winston Tan, Alan H Bryce, Roxana S Dronca, Daniel S Childs

Prostate Cancer Prostatic Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's in a Name? Why Words Matter in Advanced Prostate Cancer.
William K Oh, Neeraj Agarwal, Alan Bryce, Pedro Barata, Courtney Bugler

Eur Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024.
Alan H Bryce, Neeraj Agarwal, Himisha Beltran, Maha H Hussain, Oliver Sartor

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers.
Reagan M Barnett, Albert Jang, Sree Lanka, PIngfu Fu, Leslie A Bucheit, Alan Bryce

Commun Med (Lond)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide.
Mamta Parikh, Catherine Tangen, Maha H A Hussain, Shilpa Gupta, Sam Callis, Alan H Bryce

Eur Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate.
Haley Meyer, Rajitha Sunkara, Emily Rothmann, Amar Shah, Irbaz Riaz, Alan Haruo Bryce

Clin Genitourin Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in clinical trials for high-risk but curable prostate cancer.
Tanya Barauskas Dorff, Alan H Bryce

Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal systemic therapy in men with low-volume prostate cancer.
Akshat Saxena, Jack Andrews, Alan Haruo Bryce, Irbaz Bin Riaz

Curr Opin Urol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
Rahul Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Alan Bryce

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1.
E David Crawford, Alan H Bryce, Maha H Hussain, Neeraj Agarwal, Himisha Beltran

JU Open Plus· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2.
Alan H Bryce, E David Crawford, Neeraj Agarwal, Maha H Hussain, Himisha Beltran

JU Open Plus· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis